The leading voluntary health organization supporting eye research.    
image preview


Research News

RPB Gave $10.24 Million In Grants In 2008

New York, NY, December 19, 2008 -- Research to Prevent Blindness (RPB), the leading voluntary health organization supporting eye research, awarded 100 grants totaling $10.24 million in 2008.  Departments of ophthalmology at 56 medical... Read more...

 

Stem Cells Generate New Retinal Cells Necessary for Vision

Pluripotent stem cells — those, like embryonic stem cells, that give rise to almost every type of cell in the body — can be converted into the different classes of retinal cells necessary for vision, according to a new,... Read more...

 

Photo: Caroline Clarke

Eye Divergence in Children Linked to Risk of Mental Illness

Children whose eyes are misaligned and point outward are at significantly increased risk of developing mental illness by early adulthood, according to findings of an RPB-supported, Mayo Clinic study published this month in a Pediatrics,... Read more...

 

New Hope for Regenerating the Human Retina

In a radical breakthrough, RPB scientists have demonstrated the possibility of chemically signaling the eye's own resources to regenerate retina cells, without transplanting retinal tissue or stem cells.        ... Read more...

 

 

More RPB News

Thyroid Problems May Increase Glaucoma Risk

Gene Therapy Proven Effective for Patients with Inherited Retinal Disease

How Research to Prevent Blindness Worked To Advance Ophthalmology

Immune Cell Clues To Age-Related Macular Degeneration

Macular Degeneration, Diabetic Retinopathy Reversed

New Vision Screening Device Provides Early Warning of Diabetic Eye Disease

Research Uncovers Insufficient Vision Care for Elderly In Nursing Homes

RPB Supports Breakthrough Finding In Eye Development, Eye Cancer

RPB Supports Development of Device for Early Warning of Eye Disease

RPB Supports World Glaucoma Day

RPB-Supported Scientist Revolutionizes Gene Research

Test for Color Blindness

Artificial Cornea: New Option for the Treatment of Corneal Conditions